223 related articles for article (PubMed ID: 12409000)
21. Involvement of the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in peripheral antinociception induced by N-palmitoyl-ethanolamine in rats.
Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Cortes SF; Duarte ID
J Neurosci Res; 2012 Jul; 90(7):1474-9. PubMed ID: 22411529
[TBL] [Abstract][Full Text] [Related]
22. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to NO/cGMP and ATP-sensitive K(+) channels pathway activation in mice.
de Carvalho Veloso C; Rodrigues VG; Ferreira RC; Duarte LP; Klein A; Duarte ID; Romero TR; de Castro Perez A
Eur J Pharmacol; 2015 May; 755():1-5. PubMed ID: 25748602
[TBL] [Abstract][Full Text] [Related]
23. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway.
Durate ID; Lorenzetti BB; Ferreira SH
Eur J Pharmacol; 1990 Sep; 186(2-3):289-93. PubMed ID: 1981187
[TBL] [Abstract][Full Text] [Related]
24. Involvement of L-arginine/NO/cGMP/K(ATP) channel pathway in the peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Ghorbanzadeh B; Mansouri MT; Hemmati AA; Naghizadeh B; Mard SA; Rezaie A
Pharmacol Biochem Behav; 2014 Nov; 126():116-21. PubMed ID: 25278343
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide and potassium channels but not opioid and cannabinoid receptors mediate tramadol-induced peripheral antinociception in rat model of paw pressure withdrawal.
Soares-Santos RR; Machado DP; Romero TL; Duarte IDG
Can J Physiol Pharmacol; 2024 Mar; 102(3):218-227. PubMed ID: 37976474
[TBL] [Abstract][Full Text] [Related]
26. Role of the L-arginine-NO pathway and of cyclic GMP in electrical field-induced noradrenaline release and vasoconstriction in the rat tail artery.
Bucher B; Ouedraogo S; Tschöpl M; Paya D; Stoclet JC
Br J Pharmacol; 1992 Dec; 107(4):976-82. PubMed ID: 1334757
[TBL] [Abstract][Full Text] [Related]
27. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
Pena-dos-Santos DR; Severino FP; Pereira SA; Rodrigues DB; Cunha FQ; Vieira SM; Napimoga MH; Clemente-Napimoga JT
Neuroscience; 2009 Nov; 163(4):1211-9. PubMed ID: 19647045
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
29. Ang-(1-7) activates the NO/cGMP and ATP-sensitive K+ channels pathway to induce peripheral antinociception in rats.
Costa A; Galdino G; Romero T; Silva G; Cortes S; Santos R; Duarte I
Nitric Oxide; 2014 Feb; 37():11-6. PubMed ID: 24361899
[TBL] [Abstract][Full Text] [Related]
30. Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model.
Inoue T; Mashimo T; Shibata M; Shibuta S; Yoshiya I
Brain Res; 1998 May; 792(2):263-70. PubMed ID: 9593928
[TBL] [Abstract][Full Text] [Related]
31. Peripheral antinociception induced by δ-opioid receptors activation, but not μ- or κ-, is mediated by Ca²⁺-activated Cl⁻ channels.
Pacheco Dda F; Pacheco CM; Duarte ID
Eur J Pharmacol; 2012 Jan; 674(2-3):255-9. PubMed ID: 22134006
[TBL] [Abstract][Full Text] [Related]
32. Peripheral estradiol induces temporomandibular joint antinociception in rats by activating the nitric oxide/cyclic guanosine monophosphate signaling pathway.
Fávaro-Moreira NC; Torres-Chávez KE; Fischer L; Tambeli CH
Neuroscience; 2009 Dec; 164(2):724-32. PubMed ID: 19679171
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonists in the rostral ventral medulla of rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1994 May; 269(2):699-708. PubMed ID: 7514222
[TBL] [Abstract][Full Text] [Related]
34. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
Jain NK; Patil CS; Singh A; Kulkarni SK
Pharmacology; 2003 Mar; 67(3):150-6. PubMed ID: 12571411
[TBL] [Abstract][Full Text] [Related]
35. The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K⁺ channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats.
Gutierrez VP; Zambelli VO; Picolo G; Chacur M; Sampaio SC; Brigatte P; Konno K; Cury Y
Behav Pharmacol; 2012 Feb; 23(1):14-24. PubMed ID: 22126967
[TBL] [Abstract][Full Text] [Related]
36. Androgenic maintenance of the rat erectile response via a non-nitric-oxide-dependent pathway.
Reilly CM; Lewis RW; Stopper VS; Mills TM
J Androl; 1997; 18(6):588-94. PubMed ID: 9432131
[TBL] [Abstract][Full Text] [Related]
37. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse.
Abacioğlu N; Tunçtan B; Akbulut E; Cakici I
Life Sci; 2000; 67(10):1127-37. PubMed ID: 10954047
[TBL] [Abstract][Full Text] [Related]
38. Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin.
Hernández-Pacheco A; Araiza-Saldaña CI; Granados-Soto V; Mixcoatl-Zecuatl T
Eur J Pharmacol; 2008 Oct; 596(1-3):70-6. PubMed ID: 18755181
[TBL] [Abstract][Full Text] [Related]
39. Magnesium sulphate activates the L-arginine/NO/cGMP pathway to induce peripheral antinociception in mice.
Teixeira LRM; Castro Perez A; Lima Romero TR; Gama Duarte ID
Magnes Res; 2022 Jan; 35(1):1-10. PubMed ID: 36214549
[TBL] [Abstract][Full Text] [Related]
40. Involvement of the nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway in the antihyperalgesic effects of bovine lactoferrin in a model of neuropathic pain.
Wang J; Zhang LC; Lv YW; Ji Y; Yan XJ; Xue JP
Brain Res; 2008 May; 1209():1-7. PubMed ID: 18406400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
